BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 34095111)

  • 1. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment.
    Ni Y; Zhou X; Yang J; Shi H; Li H; Zhao X; Ma X
    Front Cell Dev Biol; 2021; 9():637675. PubMed ID: 34095111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the tumor microenvironment (TME) by melatonin.
    Mu Q; Najafi M
    Eur J Pharmacol; 2021 Sep; 907():174365. PubMed ID: 34302814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironment.
    Xiong Y; McDonald LT; Russell DL; Kelly RR; Wilson KR; Mehrotra M; Soloff AC; LaRue AC
    World J Stem Cells; 2015 Mar; 7(2):253-65. PubMed ID: 25815113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated Macrophages (TAMs) in Cancer Resistance; Modulation by Natural Products.
    Lafta HA; AbdulHussein AH; Al-Shalah SAJ; Alnassar YS; Mohammed NM; Akram SM; Qasim MT; Najafi M
    Curr Top Med Chem; 2023; 23(12):1104-1122. PubMed ID: 36722486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
    Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
    Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of the tumor immune microenvironment by metformin.
    Wu Z; Zhang C; Najafi M
    J Cell Commun Signal; 2022 Sep; 16(3):333-348. PubMed ID: 34611852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs.
    Osman A; Afify SM; Hassan G; Fu X; Seno A; Seno M
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
    Yang M; Li J; Gu P; Fan X
    Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immune regulatory cells in breast cancer: Foe or friend?
    Lan HR; Du WL; Liu Y; Mao CS; Jin KT; Yang X
    Int Immunopharmacol; 2021 Jul; 96():107627. PubMed ID: 33862552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic interactions in the tumor niche: how the cross-talk between CAFs and the tumor microenvironment impacts resistance to therapy.
    Piwocka O; Piotrowski I; Suchorska WM; Kulcenty K
    Front Mol Biosci; 2024; 11():1343523. PubMed ID: 38455762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome and mesenchymal stem cell cross-talk in the tumor microenvironment.
    Whiteside TL
    Semin Immunol; 2018 Feb; 35():69-79. PubMed ID: 29289420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.
    Zhang J; Fan J; Zeng X; Nie M; Luan J; Wang Y; Ju D; Yin K
    Acta Pharm Sin B; 2021 Mar; 11(3):609-620. PubMed ID: 33777671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk Between Mesenchymal Stromal Cells and Tumor-Associated Macrophages in Gastric Cancer.
    Zheng P; Li W
    Front Oncol; 2020; 10():571516. PubMed ID: 33163402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Cancer-Associated Fibroblasts in the Interactions of Cancer Cells with the Tumor Microenvironment of Heterogeneous Tumor Tissue.
    Arima Y; Matsueda S; Saya H
    Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Endothelial Cells (TECs) as Potential Immune Directors of the Tumor Microenvironment - New Findings and Future Perspectives.
    Nagl L; Horvath L; Pircher A; Wolf D
    Front Cell Dev Biol; 2020; 8():766. PubMed ID: 32974337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Role of
    Li Z; Zhang W; Bai J; Li J; Li H
    Front Oncol; 2022; 12():862462. PubMed ID: 35795038
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
    Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
    Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer.
    Fang B; Lu Y; Li X; Wei Y; Ye D; Wei G; Zhu Y
    Prostate Cancer Prostatic Dis; 2024 Apr; ():. PubMed ID: 38565910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression.
    Pernot S; Evrard S; Khatib AM
    Front Immunol; 2022; 13():850856. PubMed ID: 35493456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting Immunosuppressive Cell Communication Patterns Reveals JunB Proto-Oncogene (JUNB) Shaping a Non-Inflamed Tumor Microenvironment.
    Chen H; Chen G
    Front Genet; 2022; 13():883583. PubMed ID: 35812726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.